USA: A new study published in the Journal of Diabetes and Its Complications suggests that tirzepatide, a novel dual ...

Spraying pesticides for a living increases the risk of erectile dysfunction. Our denial of this fact may mask a deeper fear: ...

Postoperative penile hypoxia is one potential contributor, Pedersen and co-authors noted. The rationale for LI-SWT to treat ...

Your blood sugar can affect more than your propensity for diabetes. In fact, high blood sugar may be causing you to lose out ...

Tirzepatide significantly reduced the risk of progression to diabetes in adults with prediabetes and obesity or overweight.

Tirzepatide shows promise in reducing weight and preventing diabetes progression in people with obesity and prediabetes, with lasting benefits and manageable side effects.

A study published in eClinicalMedicine found that tirzepatide outperforms semaglutide in reducing the risk of type 2 diabetes and major cardiovascular events among individuals with obesity, with ...

The primary purpose was to evaluate the long term effects of tirzepatide on body weight and on the risk of developing type 2 diabetes.

Tirzepatide showed a 38% reduction in the risk of heart failure outcomes, assessed as a composite endpoint, compared to placebo. Risk of hospitalization for heart failure was reduced by 56%.

For the efficacy estimand ii, pooled doses of tirzepatide achieved significant results, demonstrating a 94% reduction in risk of progression to type 2 diabetes compared to placebo up to week 176.

Tirzepatide lowered the risk for progression to type 2 diabetes among adults with prediabetes and overweight or obesity in the SURMOUNT-1 3-year trial.